FIELD: medicine.
SUBSTANCE: invention refers to medical agents normalising urination, and can be used as means for correction of dysuric disorders of various geneses, including caused by infectious-inflammatory and neuroendocrinological factors. There is declared pharmaceutical composition normalising urination, containing as a reactant, peptide glutamyl- aspartic acid in effective amount of general formula: H-Glu-Asp-OH of a sequences 1 [SEQ ID NO:1] and a pharmaceutically acceptable carrier. There is declared agent containing peptide- aspartic acid of general formula: H-Glu-Asp-OH of a sequence 1 [SEQ ID NO:1] showing biological activity with regard to normalising urination. There is disclosed method of detrusor-sphincter continence consisting in introduction to the patient of the pharmaceutical composition containing as a reactant, peptide glutamyl- aspartic acid in effective amount of general formula: H-Glu-Asp-OH of a sequence 1 [SEQ ID NO:1].
EFFECT: enabled normalising of urination by detrusor-sphincter continence.
5 cl, 6 ex, 3 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
TETRAPEPTIDE REGULATING PROSTATE FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2001 |
|
RU2177802C1 |
PEPTIDE ENHANCING RESISTANCE OF CAPILLARIES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2295970C1 |
PEPTIDE NORMALIZING METABOLISM IN OSSEOUS AND CARTILAGE TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2299741C1 |
PEPTIDE STIMULATING REGENERATION OF LIVER TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2297239C1 |
PEPTIDE STIMULATING REGENERATION OF CENTRAL NERVOUS SYSTEM NEURONS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301678C1 |
PEPTIDE POSSESSING IMMUNOGEROPROTECTIVE EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301074C1 |
PHARMACEUTICAL COMPOSITION ON BASIS OF PEPTIDE POSSESSING ANTITUMORAL ACTION | 2007 |
|
RU2362579C1 |
PEPTIDE POSSESSING STRESS-PROTECTING EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2304444C1 |
PHARMACEUTICAL COMPOSITION BASED ON PEPTIDE REGULATING DISTURBANCES OF ANGIOGENESIS, AND WAY OF ITS APPLICATION | 2007 |
|
RU2363488C1 |
TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF NEURONS, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 1999 |
|
RU2155063C1 |
Authors
Dates
2009-09-20—Published
2007-11-26—Filed